Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Oct 17 - Oct 22
Antifibrotic effect of pirfenidone in a mouse model of human nonalcoholic steatohepatitis
In August 2024, Metsera, a newly launched clinical-stage biopharmaceutical company, emerged with a significant US$ 290 million in funding to develop innovative treatments for obesity and metabolic diseases, particularly focusing on GLP-1 receptor agonists
The CEO has agreed to testify before the Senate Committee on Health, Education, Labor and Pensions in September 2024
Understanding cagrisema vs retatrutide is essential for researchers navigating this rapidly evolving field in 2026
Sympathetic neural control of the kidney in hypertension
US$ 25.38
US$ 25.28
US$ 21.76
US$ 29.87
US$ 26.17
US$ 24.35
